MEF2C and stroke disorder: Our findings reveal a novel mechanism of how hyperlipidemia comorbidity exacerbates ischemic brain injury after stroke and identify neuronal CflarR splicing regulated by Mef2c as a new therapeutic target for neuroprotection of stroke patients with hyperlipidemia.